Free tool
FAERS Monitor: Velphoro
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 205109 or its brand name (Velphoro, Ferric Oxyhydroxide). Reports on generic versions are filed under their own applications.
Reports
3,046
Serious
2,193
72% of reports
Hospitalization
556
Death reported
1,293
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- death1,146
- diarrhoea328
- nausea100
- constipation90
- hospitalisation88
- vomiting87
- faeces discoloured84
- drug intolerance68
- abdominal discomfort63
- off label use61
- product taste abnormal60
- abdominal pain53
- end stage renal disease52
- chronic kidney disease50
- pruritus47
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2014 | 25 |
| 2015 | 131 |
| 2016 | 135 |
| 2017 | 259 |
| 2018 | 284 |
| 2019 | 479 |
| 2020 | 661 |
| 2021 | 320 |
| 2022 | 114 |
| 2023 | 105 |
| 2024 | 195 |
| 2025 | 216 |
| 2026 | 122 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,051,113 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| product taste abnormalSignal | 60 | 30.7 | 23.9 | 1,690 |
| faeces discolouredSignal | 84 | 26.9 | 21.7 | 2,060 |
| end stage renal diseaseSignal | 52 | 19.7 | 15.1 | 905 |
| deathSignal | 1,146 | 9.2 | 8.8 | 8,709 |
| drug intoleranceSignal | 68 | 4.9 | 3.8 | 206 |
| chronic kidney diseaseSignal | 50 | 4.5 | 3.5 | 135 |
| hospitalisationSignal | 88 | 4.0 | 3.2 | 193 |
| diarrhoeaSignal | 328 | 3.5 | 3.2 | 604 |
| constipationSignal | 90 | 2.9 | 2.3 | 107 |
| abdominal discomfortSignal | 63 | 2.6 | 2.0 | 61 |
| abdominal pain | 53 | 1.6 | 1.2 | 11 |
| vomiting | 87 | 1.3 | 1.0 | 5 |
| nausea | 100 | 0.9 | 0.7 | 2 |
| pruritus | 47 | 0.8 | 0.6 | 1 |
| off label use | 61 | 0.5 | 0.4 | 35 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.